These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 20003451)
1. Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome. Vosters JL; Yin H; Roescher N; Kok MR; Tak PP; Chiorini JA Arthritis Res Ther; 2009; 11(6):R189. PubMed ID: 20003451 [TBL] [Abstract][Full Text] [Related]
2. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome. Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166 [TBL] [Abstract][Full Text] [Related]
3. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370 [TBL] [Abstract][Full Text] [Related]
4. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699 [TBL] [Abstract][Full Text] [Related]
5. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer. Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230 [TBL] [Abstract][Full Text] [Related]
6. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB; Nguyen CQ; Ambrus J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965 [TBL] [Abstract][Full Text] [Related]
7. Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation. Roescher N; Vosters JL; Lai Z; Uede T; Tak PP; Chiorini JA PLoS One; 2012; 7(12):e51375. PubMed ID: 23300544 [TBL] [Abstract][Full Text] [Related]
8. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. Fox RI; Kang HI; Ando D; Abrams J; Pisa E J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070 [TBL] [Abstract][Full Text] [Related]
9. Injection of CD40 DNA vaccine ameliorates the autoimmune pathology of non-obese diabetic mice with Sjögren's syndrome. Zhou YB; Yuan X; Wang QK; Zhang H; Wang GS; Li XP; Wang Y; Harris D; Li XM Immunol Lett; 2020 Oct; 226():62-70. PubMed ID: 32707129 [TBL] [Abstract][Full Text] [Related]
11. A role for lymphotoxin in primary Sjogren's disease. Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683 [TBL] [Abstract][Full Text] [Related]
12. Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren's syndrome. Wen J; Zhu F; Yu X; Xie H; Li C BMC Immunol; 2022 Oct; 23(1):49. PubMed ID: 36244973 [TBL] [Abstract][Full Text] [Related]
13. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger? Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931 [TBL] [Abstract][Full Text] [Related]
14. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model. Jin JO; Shinohara Y; Yu Q PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035 [TBL] [Abstract][Full Text] [Related]
15. Endogenous IL-22 contributes to the pathogenesis of salivary gland dysfunction in the non-obese diabetic model of Sjögren's syndrome. Felix FA; Zhou J; Li D; Onodera S; Yu Q Mol Immunol; 2024 Sep; 173():20-29. PubMed ID: 39018744 [TBL] [Abstract][Full Text] [Related]
16. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice. Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030 [TBL] [Abstract][Full Text] [Related]
17. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793 [TBL] [Abstract][Full Text] [Related]
18. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863 [TBL] [Abstract][Full Text] [Related]
19. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability. Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769 [TBL] [Abstract][Full Text] [Related]
20. IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22. Wu C; Wang Z; Zourelias L; Thakker H; Passineau MJ Arthritis Res Ther; 2015 Aug; 17(1):198. PubMed ID: 26245278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]